[1]
|
J. F. Bach, “The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases,” The New England Journal of Medicine, Vol. 347, No. 12, 2002, pp. 911-920. doi:10.1056/NEJMra020100
|
[2]
|
M. Inaba, S. Ushijim, N. Hirata, et al., “Methotrexate-Related Lyphomatoid Granulomatosis in a Patient with Rheumatoid Arthritis,” Nihon Kokyuki Gakkai Zasshi, Vol. 49, No. 8, 2011, pp. 597-601.
|
[3]
|
M. D. Mayes, “Epidemiologic Studies of Environmental Agents and Systemic Autoimmune Diseases,” Environmental Health Perspectives, Vol. 107, Supplement 5, 1999, pp. 743-748
|
[4]
|
O. V. Pishak, “Bukovian State Medical Academy, Public Health Ministry of Ukraine,” Mikrobiolohichnyi Zhurnal, Vol. 61, No. 5, 1999, pp. 41-47.
|
[5]
|
H. Tiwana, C. Wilson, R. S. Walmsley, et al., “Antibody Responses to Gut Bacteria in Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s Disease and Ulcerative Colitis,” Rheumatology International, Vol. 17, No. 1, 1997, pp. 11-16. doi:10.1007/PL00006845
|
[6]
|
A. Ebringer and T. Rahid, “Rheumatoid Arthritis Is an Autoimmune Disease Triggered by Proteus Urinary Tract Infection,” Clinical and Developmental Immunology, Vol. 13, No. 1, 2006, pp. 41-48.
doi:10.1080/17402520600576578
|
[7]
|
A. Ebringer, T. Rahid and C. Wilson, “Rheumatoid Arthritis: Proposal for the Use of Anti-Microbial Therapy in Early Cases,” Scandinavian Journal of Rheumatology, Vol. 32, No. 1, 2003, pp. 2-11.
doi:10.1080/03009740310000337
|
[8]
|
F. Liao, Z. Li, Y. Wang, et al., “Porphyromonas Gingivalis May Play an Important Role in the Pathogenesis of Periodontitis-Associated Rheumatoid Arthritis,” Medical Hypotheses, Vol. 72, No. 6, 2009, pp. 732-735.
|
[9]
|
M. Harkiolaki, S. L. Holmes, P. Svendsen, et al., “T-Cell-Mediated Autoimmune Disease Due to Low-Affinity Cross Reactivity to Common Microbial Peptides,” Immunity, Vol. 30, No. 3, 2009, pp. 348-357.
doi:10.1016/j.immuni.2009.01.009
|
[10]
|
S. K. Mazmanian, J. L. Round and D. L. Kasper, “A Microbial Symbiosis Factor Prevents Intestinal Inflammatory Disease,” Nature, Vol. 453, No. 7195, 2008, pp. 620-625. doi:10.1038/nature07008
|
[11]
|
G. Petru, D. Stunzner, P. Lind, et al., “Antibodies to Yersinia Enterocolitica in Immunogenic Thyroid Diseases,” Acta Medica Austriaca, Vol. 14, No. 1, 1987, pp. 11-14.
|
[12]
|
N. Anasaldi, T. Palmas, A. Corrias, et al., “Autoimmune Thyroid Disease and Celiac Disease in Children,” Journal of Pediatric Gastroenterology and Nutrition, Vol. 37, No. 1, 2003, pp. 63-66.
doi:10.1097/00005176-200307000-00010
|
[13]
|
D. Brady, “Novel Options in GI Diagnostics: DNA Detection of Gut Microbiota,” Complementary Medicine, 2008, pp. 28-31.
|
[14]
|
S. T. Weiss, “Eat Dirt—The Hygiene Hypothesis and Allergic Disease (Editorial),” The New England Journal of Medicine, Vol. 347, No. 12, 2002, pp. 930-931.
doi:10.1056/NEJMe020092
|
[15]
|
E. von Mutius and D. Vercelli, “Farm Living: Effects on Childhood Asthma and Allergy,” Nature Reviews Immunology, Vol. 10, No. 12, 2010, pp. 861-868.
doi:10.1038/nri2871
|
[16]
|
D. Gutierrez, “Parasites in Your Gut Actually Help Protect You from Allergies,” NaturalNews, 2011.
http://www.naturalnews.com/028141_parasites_allergies.html.
|
[17]
|
R. W. Summers, D. E. Elliott, J. V. Weinstock, et al., “Trichuris Suis Seems to Be Safe and Possibly Effective in the Treatment of Inflammatory Bowel Disease,” The American Journal of Gastroenterology, Vol. 98, No. 9, 2003, pp. 2034-2041.
doi:10.1111/j.1572-0241.2003.07660.x
|
[18]
|
A Fasano and T. Shea-Donohue, “Mechanisms of Disease: The Role of Intestinal Barrier Function in the Pathogenesis of Gastrointestinal Autoimmune Diseases,” Nature Clinical Practice Gastroenterology & Hepatology, Vol. 2, No. 9, 2005, pp. 416-422. doi:10.1038/ncpgasthep0259
|
[19]
|
A. Fasano, “Surprises from Celiac Disease,” Scientific American, Vol. 301, No. 2, 2009, pp. 54-61.
doi:10.1038/scientificamerican0809-54
|
[20]
|
A. Sapone, L. de Magistris and M. Pietzak, “Zonulin Upregulation Is Associated with Increased Gut Permeability in Subjects with Type I Diabetes and Their Relatives,” Diabetes, Vol. 55, No. 5, 2006, pp. 1443-1449.
doi:10.2337/db05-1593
|
[21]
|
J. Kong, Z. Zhang, M. W. Musch, et al., “Novel Role of the Vitamin D Receptor in Maintaining the Integrity of the Intestinal Mucosal Barrier,” American Journal of Physiology—Gastrointestinal and Liver Physiology, Vol. 294, No. 1, 2008, pp. G208-G216.
doi:10.1152/ajpgi.00398.2007
|
[22]
|
S. Y. Yao, C. W. Stratton and W. M. Mitchell, “CSF Oligoclonal Bands in MS Include Antibodies against Chlamydophilia Antigens,” Neurology, Vol. 56, No. 9, 2001, pp. 1168-1176. doi:10.1212/WNL.56.9.1168
|
[23]
|
D. H. Gilden, “Infectious Causes of Multiple Sclerosis,” The Lancet Neurology, Vol. 4, No. 3, 2005, pp. 195-202.
|
[24]
|
A. F. Gombart, N. Borregaard and H. P. Koeffler, “Human Cathelicidin Antimicrobial Peptide (Camp) Gene Is a Direct Target of the Vitamin D Receptor and Is Strongly Up-Regulated in Myeloid Cells by 1,25-Hihydroxyvitamin D3,” Future Microbiology, Vol. 4, No. 9, 2009, pp. 1151-1165. doi:10.2217/fmb.09.87
|
[25]
|
A. L. Notkins, “New Predictors of Disease,” Scientific American, Vol. 296, No. 3, 2007, pp. 72-79.
doi:10.1038/scientificamerican0307-72
|
[26]
|
D. Leslie, P. Lipsky and A. L. Notkins, “Autoantibodies as Predictors of Disease,” Journal of Clinical Investigation, Vol. 108, No. 10, 2001, pp. 1417-1422.
|
[27]
|
T. O’Bryan, “American College for Advancement in Medicine Annual Symposium Presentation 2009”.
|
[28]
|
Y. Shoenfeld, M. Blank, M. Abu-Shakra, et al., “The Mosaic of Autoimmunity: Prediction, Autoantibodies, and Therapy in Autoimmune Disease,” IMAJ, Vol. 10, No. 1, 2008, pp. 13-19.
|
[29]
|
B. Lindberg, S. A. Iverson, et al., “Islet Autoantibodies in Cord Blood in Children Who Develop Type I (Insulin-Dependent) Diabetes Mellitus before 15 Years of Age,” Diabeteologia, Vol. 42, No. 2, 1999, pp. 181-187.
doi:10.1007/s001250051137
|
[30]
|
A. Vojdani, “Antibodies as Predictors of Complex Autoimmune Diseases and Cancer,” International Journal of Immunopathology and Pharmacology, Vol. 21, No. 3, 2008, pp. 553-566.
|